. Mechanism of BPA-and Nar-dependent control of ERa degradation. Western blot analysis of ERa (panels A-C) or ubiquitin (panel C) cellular levels in MCF-7 cells treated with vehicle (-), E2, Nar or BPA for 24 hours in the presence of 60 min pre-treatment with cycloheximide (CHX) 1 mg/ml before ligand administration (panel A); or with E2, Nar, and CHX (1 mg/ml) at the indicated time points (panel B); or with E2 or BPA for 24 hours in the presence of 60 min pretreatment with the 26S proteasome inhibitor Mg132 (1 mg/ml) before ligand administration (panel C). * indicates significant differences with respect to the control sample; u indicates significant differences with respect to the corresponding non stimulated samples. doi:10.1371/journal.pone.0088961.g005
